European Archives of Oto-Rhino-Laryngology

, Volume 259, Issue 5, pp 253–256 | Cite as

Effects of intravenous administration of prostaglandin E1 and lipo-prostaglandin E1 on cochlear blood flow in guinea pigs

  • Tadashi Nishimura
  • Kazuhiko Nario
  • Hiroshi Hosoi
Otology

Abstract

Prostaglandin E1 (PGE1), a vasodilator and an inhibitor of platelet aggregation, has been used for the treatment of idiopathic sudden sensorineural hearing loss, despite the fact that its effectiveness has not been proven. Furthermore, it is rapidly metabolized in the lungs, which makes it difficult to use clinically. In an attempt to prevent this, PGE1 was coated with a 0.2-µg lipid microsphere produced by beans; this was designated lipo-PGE1. This coating protects PGE1 from being rapidly metabolized. In this study, the effectiveness of the intravenous administration of lipo-PGE1 was compared with that of PGE1 by investigating the effects on systemic blood pressure (SBP) and cochlear blood flow (CBF) in guinea pigs with normal ears. The results of both drugs showed a dose-dependent decrease in SBP and the maintenance of CBF despite the decrease in SBP. However, no significant increase in CBF was observed for either drug. In comparing the effects of PGE1 and lipo-PGE1, no obvious differences in the effects on SBP and CBF were observed in this study.

Prostaglandin E1 Lipo-prostagrandin E1 Cochlear blood flow Laser Doppler flowmeter 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Copyright information

© Springer-Verlag 2002

Authors and Affiliations

  • Tadashi Nishimura
    • 1
  • Kazuhiko Nario
    • 2
  • Hiroshi Hosoi
    • 1
  1. 1.Department of Otolaryngology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, JapanJapan
  2. 2.Department of Otolaryngology, Osaka Prefectural General Hospital, Osaka, JapanJapan

Personalised recommendations